Significant Cardiac Benefit Seen With Ifetroban in Patients With Duchenne Muscular Dystrophy
Apitegromab Improved Motor Function in Type 2/3 Spinal Muscular Atrophy
Losmapimod Did Not Benefit Patients with Facioscapulohumeral Muscular Dystrophy